Theranostics 2016; 6(9):1425-1439. doi:10.7150/thno.15359 This issue Cite

Review

Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells

Jie-Fu Chen1†, Yazhen Zhu2,3†, Yi-Tsung Lu1†, Elisabeth Hodara1, Shuang Hou3, Vatche G. Agopian4,5, James S. Tomlinson4,6,7, Edwin M. Posadas1✉, Hsian-Rong Tseng2 ✉

1. Urologic Oncology Program and Uro-Oncology Research Laboratories, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA;
2. Department of Molecular and Medical Pharmacology, California NanoSystems Institute, Crump Institute for Molecular Imaging, University of California, Los Angeles, Los Angeles, California, USA;
3. Department of Pathology, Guangdong Provincial Hospital of TCM, Guangzhou University of Chinese Medicine, Guangzhou, China.
4. Department of Surgery, University of California, Los Angeles, Los Angeles, California, USA;
5. Liver Transplantation and Hepatobiliary Surgery, University of California, Los Angeles, Los Angeles, California, USA;
6. Center for Pancreatic Disease, University of California, Los Angeles, Los Angeles, California, USA;
7. Department of Surgery Greater Los Angeles Veteran's Affairs Administration, Los Angeles, California, USA.
These authors contribute equally to this work.

Citation:
Chen JF, Zhu Y, Lu YT, Hodara E, Hou S, Agopian VG, Tomlinson JS, Posadas EM, Tseng HR. Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells. Theranostics 2016; 6(9):1425-1439. doi:10.7150/thno.15359. https://www.thno.org/v06p1425.htm
Other styles

File import instruction

Abstract

Graphic abstract

Liquid biopsy of tumor through isolation of circulating tumor cells (CTCs) allows non-invasive, repetitive, and systemic sampling of disease. Although detecting and enumerating CTCs is of prognostic significance in metastatic cancer, it is conceivable that performing molecular and functional characterization on CTCs will reveal unprecedented insight into the pathogenic mechanisms driving lethal disease. Nanomaterial-embedded cancer diagnostic platforms, i.e., NanoVelcro CTC Assays represent a unique rare-cell sorting method that enables detection isolation, and characterization of CTCs in peripheral blood, providing an opportunity to noninvasively monitor disease progression in individual cancer patients. Over the past decade, a series of NanoVelcro CTC Assays has been demonstrated for exploring the full potential of CTCs as a clinical biomarker, including CTC enumeration, phenotyping, genotyping and expression profiling. In this review article, the authors will briefly introduce the development of three generations of NanoVelcro CTC Assays, and highlight the clinical applications of each generation for various types of solid cancers, including prostate cancer, pancreatic cancer, lung cancer, and melanoma.

Keywords: Circulating tumor cell


Citation styles

APA
Chen, J.F., Zhu, Y., Lu, Y.T., Hodara, E., Hou, S., Agopian, V.G., Tomlinson, J.S., Posadas, E.M., Tseng, H.R. (2016). Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells. Theranostics, 6(9), 1425-1439. https://doi.org/10.7150/thno.15359.

ACS
Chen, J.F.; Zhu, Y.; Lu, Y.T.; Hodara, E.; Hou, S.; Agopian, V.G.; Tomlinson, J.S.; Posadas, E.M.; Tseng, H.R. Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells. Theranostics 2016, 6 (9), 1425-1439. DOI: 10.7150/thno.15359.

NLM
Chen JF, Zhu Y, Lu YT, Hodara E, Hou S, Agopian VG, Tomlinson JS, Posadas EM, Tseng HR. Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells. Theranostics 2016; 6(9):1425-1439. doi:10.7150/thno.15359. https://www.thno.org/v06p1425.htm

CSE
Chen JF, Zhu Y, Lu YT, Hodara E, Hou S, Agopian VG, Tomlinson JS, Posadas EM, Tseng HR. 2016. Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells. Theranostics. 6(9):1425-1439.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image